Free Trial
OTCMKTS:NPHC

Nutra Pharma (NPHC) Stock Price, News & Analysis

Nutra Pharma logo
$0.0001 0.00 (-66.67%)
As of 04/23/2025 09:51 AM Eastern

About Nutra Pharma Stock (OTCMKTS:NPHC)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0003
Volume
231,707 shs
Average Volume
115,020 shs
Market Capitalization
$709,974.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, nonnarcotic, nonaddictive, and overthecounter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and antiinflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.

Receive NPHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutra Pharma and its competitors with MarketBeat's FREE daily newsletter.

NPHC Stock News Headlines

Nutra Pharma Corp (NPHC)
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
Nutra Pharma Corp. Reaches Settlement with SEC
Collegium Pharmaceutical
Nutra Pharma Corp.
Nutri Pharmaceuticals Research Inc.
See More Headlines

NPHC Stock Analysis - Frequently Asked Questions

Nutra Pharma's stock was trading at $0.0001 at the beginning of the year. Since then, NPHC shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here
.

Nutra Pharma Corp. (OTCMKTS:NPHC) issued its quarterly earnings results on Friday, August, 17th. The company reported $0.00 earnings per share for the quarter. The company had revenue of $0.03 million for the quarter.

Shares of NPHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutra Pharma investors own include SMART Global (SGH), Jumia Technologies (JMIA), America First Multifamily Investors (ATAX), Prospect Capital (PSEC), Tilray (TLRY), AGNC Investment (AGNC) and Akoustis Technologies (AKTS).

Company Calendar

Last Earnings
8/17/2018
Today
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:NPHC
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,099,740,000
Free Float
2,733,400,000
Market Cap
$709,974.00
Optionable
Not Optionable
Beta
-0.31
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:NPHC) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners